These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 37298772)
1. Docking-Based Evidence for the Potential of ImmunoDefender: A Novel Formulated Essential Oil Blend Incorporating Synergistic Antiviral Bioactive Compounds as Promising Mpro Inhibitors against SARS-CoV-2. Ksouri A; Klouz A; Bouhaouala-Zahar B; Moussa F; Bezzarga M Molecules; 2023 May; 28(11):. PubMed ID: 37298772 [TBL] [Abstract][Full Text] [Related]
2. Repositioning of anti-dengue compounds against SARS-CoV-2 as viral polyprotein processing inhibitor. Bajrai LH; Faizo AA; Alkhaldy AA; Dwivedi VD; Azhar EI PLoS One; 2022; 17(11):e0277328. PubMed ID: 36383621 [TBL] [Abstract][Full Text] [Related]
3. Biflavonoids from Lokhande K; Nawani N; K Venkateswara S; Pawar S J Biomol Struct Dyn; 2022 Jul; 40(10):4376-4388. PubMed ID: 33300454 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 proteases Mpro and PLpro: Design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations. Tumskiy RS; Tumskaia AV; Klochkova IN; Richardson RJ Comput Biol Med; 2023 Feb; 153():106449. PubMed ID: 36586228 [TBL] [Abstract][Full Text] [Related]
5. Amentoflavone derivatives significantly act towards the main protease (3CL Dey D; Hossain R; Biswas P; Paul P; Islam MA; Ema TI; Gain BK; Hasan MM; Bibi S; Islam MT; Rahman MA; Kim B Mol Divers; 2023 Apr; 27(2):857-871. PubMed ID: 35639226 [TBL] [Abstract][Full Text] [Related]
6. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation. Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783 [TBL] [Abstract][Full Text] [Related]
7. Some Flavolignans as Potent Sars-Cov-2 Inhibitors Cetin A Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852 [TBL] [Abstract][Full Text] [Related]
8. In silico screening of potential inhibitors from Cordyceps species against SARS-CoV-2 main protease. Deshmukh N; Talkal R; Lakshmi B J Biomol Struct Dyn; 2024 Jun; 42(9):4395-4411. PubMed ID: 37325819 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2021 Aug; 39(12):4362-4374. PubMed ID: 32568613 [TBL] [Abstract][Full Text] [Related]
10. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations. Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993 [TBL] [Abstract][Full Text] [Related]
11. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods. Sharma P; Joshi T; Mathpal S; Joshi T; Pundir H; Chandra S; Tamta S J Biomol Struct Dyn; 2022 Apr; 40(6):2757-2768. PubMed ID: 33143552 [TBL] [Abstract][Full Text] [Related]
12. Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery. Ray AK; Sen Gupta PS; Panda SK; Biswal S; Bhattacharya U; Rana MK Comput Biol Med; 2022 Mar; 142():105183. PubMed ID: 34986429 [TBL] [Abstract][Full Text] [Related]
13. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease. Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19). El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721 [TBL] [Abstract][Full Text] [Related]
16. Antiviral peptides inhibiting the main protease of SARS-CoV-2 investigated by computational screening and in vitro protease assay. Stewart J; Shawon J; Ali MA; Williams B; Shahinuzzaman ADA; Rupa SA; Al-Adhami T; Jia R; Bourque C; Faddis R; Stone K; Sufian MA; Islam R; McShan AC; Rahman KM; Halim MA J Pept Sci; 2024 Apr; 30(4):e3553. PubMed ID: 38031661 [TBL] [Abstract][Full Text] [Related]
17. In silico study of alkaloids with quercetin nucleus for inhibition of SARS-CoV-2 protease and receptor cell protease. Mohebbi A; Eskandarzadeh M; Zangi H; Fatehi M PLoS One; 2024; 19(4):e0298201. PubMed ID: 38626042 [TBL] [Abstract][Full Text] [Related]